Your browser doesn't support javascript.
loading
An Economic Evaluation of Pharmacological Therapy and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia / 대한비뇨기과학회지
Korean Journal of Urology ; : 619-623, 2002.
Article in Korean | WPRIM | ID: wpr-48129
ABSTRACT

PURPOSE:

An economic analysis of pharmacological therapy and transurethral resection of the prostate (TURP) for patients with benign prostatic hyperplasia (BPH) was conducted. MATERIALS AND

METHODS:

Twenty six patients had undergone TURP from January to June 2000 were enrolled in this study. The costs associated with this group of patients were compared with those of 7 patients treated with medication (doxazosin, terazosin, tamsulosin, and finasteride only and alpha-blocker with finasteride).

RESULTS:

The mean cost for TURP was 1,900,000 won. The most expensive medical therapy was finasteride, which was followed by tamsulosin, terazosin, and doxazosin, with an estimated 12-month cost of 817,000won, 695,000won, 396,000won, and 372,000won respectively. The costs associated with doxazosin remained lower than those associated with TURP for approximately 5.3 years (the corresponding break-even point was 2.4 years for finasteride vs. TURP).

CONCLUSIONS:

Among the pharmacological therapies, doxazosin is the most cost effective. TURP was more cost effective than doxazosin therapy after 5.3 years. In view of the cost-effectiveness, TURP may be considered as the mode of primary therapy for the patients with severe symptoms of BPH.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prostate / Prostatic Hyperplasia / Doxazosin / Finasteride / Transurethral Resection of Prostate Type of study: Health economic evaluation Limits: Humans Language: Korean Journal: Korean Journal of Urology Year: 2002 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prostate / Prostatic Hyperplasia / Doxazosin / Finasteride / Transurethral Resection of Prostate Type of study: Health economic evaluation Limits: Humans Language: Korean Journal: Korean Journal of Urology Year: 2002 Type: Article